In the case of lung cancer, there were genetic mutations (K-ras) contributing to VTE. Moreover, those who generally have a slower-growing and more indolent malignancy, such as breast cancer and prostate cancer, had much lower incidences of developing VTE (1%) [10,11]. The gene discussed is KRAS; the disease is Familial prostate cancer.